1. Home
  2. PJT vs DYN Comparison

PJT vs DYN Comparison

Compare PJT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PJT Partners Inc.

PJT

PJT Partners Inc.

HOLD

Current Price

$150.84

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.14

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PJT
DYN
Founded
2014
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.8B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PJT
DYN
Price
$150.84
$17.14
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$178.50
$37.00
AVG Volume (30 Days)
312.4K
2.8M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
0.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,713,671,000.00
N/A
Revenue This Year
$11.12
N/A
Revenue Next Year
$9.98
N/A
P/E Ratio
$23.03
N/A
Revenue Growth
14.77
N/A
52 Week Low
$127.73
$11.92
52 Week High
$195.62
$27.31

Technical Indicators

Market Signals
Indicator
PJT
DYN
Relative Strength Index (RSI) 27.44 22.61
Support Level $144.58 $16.55
Resistance Level $163.37 $19.54
Average True Range (ATR) 5.97 1.14
MACD -3.67 -0.64
Stochastic Oscillator 3.28 0.87

Price Performance

Historical Comparison
PJT
DYN

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services, and others. Geographically, it generates maximum revenue from the United States, followed by the United Kingdom and other markets.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: